3mensio vascular imaging software receives FDA approval
The FDA has granted 3mensio Medical Imaging a 510(k) clearance to market the 3surgery vascular imaging (VI) software.
The software provides a clinical application for vascular surgeons using CT angiography or MR angiography studies to determine abnormalities of the vessels within thorax or abdomen, both in 2D and 3D, the Bilthoven, Netherlands-based company said. 3surgery VI provides tools for stent and graft planning of endovascular procedures.
The company said techniques like endovascular aneurysm repair (EVAR) rely on an accurate diagnosis and measurements using 2D and 3D images from the radiology department. 3surgery VI software provides the tools for the pre and post operative planning of procedures on a PC, 3mensio said.
The software provides a clinical application for vascular surgeons using CT angiography or MR angiography studies to determine abnormalities of the vessels within thorax or abdomen, both in 2D and 3D, the Bilthoven, Netherlands-based company said. 3surgery VI provides tools for stent and graft planning of endovascular procedures.
The company said techniques like endovascular aneurysm repair (EVAR) rely on an accurate diagnosis and measurements using 2D and 3D images from the radiology department. 3surgery VI software provides the tools for the pre and post operative planning of procedures on a PC, 3mensio said.